Clinical Trial Agreement Considerations for Pharmaceutical Sponsors

Clinical trial sponsors often underestimate the importance of spending appropriate time and resources on clinical trial agreements (CTAs). This practice note focuses on key CTA provisions that, if overlooked, can be very costly for organizations.

Read now »

Related Content

• FDA Drug Regulatory Activity Tracker
  Check out this tracker for a summary of FDA regulatory activity, including in the clinical trials space, action items for attorneys including effective dates and compliance dates, deadlines for submitting comments in response to FDA proposed rules and draft guidance, and other key information.

Practical Guidance Updates
Featuring the latest updates from your Practical Guidance account.

• For Practical Guidance content on important recent trends, review these easy-to-use Resource Kits:
  • Generative Artificial Intelligence (AI) Resource Kit
  • Chevron Reversal Impact Resource Kit

• Document alerts allow you to stay current on legal developments that affect your practice. Find out how to set up your document alerts. 
• Legal Developments provide the latest updates and analyses of emerging topics impacting your practice area. Visit the Legal Developments page to see the latest topics, which also include breaking legal news and related Practical Guidance content.
• Learn about the 2000+ leading attorney authors contributing to our 26 practice areas in the Practical Guidance Author Center. Interested in becoming a Practical Guidance author? Click here for details. Practical Guidance is committed to amplifying diverse voices of attorneys across all differences, including gender and race.

PRACTICAL GUIDANCE CUSTOMER EMAIL EDITION ON THE WEB

Experience results today with practical guidance, legal research, and data-driven insights—all in one place.

Experience Lexis+